TRACON (TCON): Company Cash Volume

Corporate emblem and logo of TRACON Pharmaceuticals, Inc. (TCON)

TRACON Pharmaceuticals (TCON) is establishing an oncology research network, combining the search for tumor treatments with antibody testing. The company's free cash flow reflects the impact of laboratory expenses, where scalability depends on future royalty payments. However, the failure of a key test led to asset liquidation and a market exit, meaning the current status is 0.00.

TRACON Pharmaceuticals, Inc - TCON Company Cash Volume (period 07/04/2022 - 08/04/2024)

Analytical breakdowns and data insights for company TRACON Pharmaceuticals, Inc. (TCON)

- stock quotes and analyst forecast:
Fundamental company analysis:TRACON Pharmaceuticals, Inc
Brand item of traconpharma.com

For TRACON Pharmaceuticals (TCON), available capital is becoming the key measure of efficiency for liquidation processes following the cessation of research. This metric aggregates the total value of liquid assets, determining the business's ability to cover liabilities without external borrowing. By analyzing the company's cash reserves, an investor assesses the burn rate of remaining assets. Management transparency ensures these reserves are protected from misappropriation. The final balance confirms the level of financial autonomy during the winding down of operations.

Analysis of competing companies

Company Cash Volume TEM|QGEN - Company Cash Reserve|ionispharma.com - Company Cash on Hand|Company Cash Balance RGEN|Avidity Corp - Company Cash Volume|CRISPR Therapeutics Corp - Company Total Cash Amount|GeneDx Holdings (WGS) - Company Cash Funds|Ultragenyx Pharmaceutical (RARE) - Company Cash Volume|Company Cash on Hand BEAM|Sarepta (SRPT) - Company Liquid Assets|Company Cash Funds Twist Bioscience Corp (TWST)|10x - Company Cash and Cash Equivalents|Company Cash Volume NTLA (intelliatx.com)|Company Total Cash Amount STOK (stoketherapeutics.com)|BioLife Solutions Inc - Company Cash Volume|WVE (Wave Life Sciences Ltd) - Company Cash and Cash Equivalents|Maze Therapeutics Corp (MAZE) - Company Cash Funds|Company Cash and Cash Equivalents SION|PRME (Prime Medicine Inc) - Company Cash Volume|Taysha Gene Therapies (TSHA) - Company Liquid Assets|Company Cash on Hand QURE (uniqure.com)|Company Total Cash Amount MGTX|Company Cash Volume RGNX (regenxbio.com)|SLDB: Company Cash and Cash Equivalents|ocugen.com - Company Cash Volume|PACB - Company Cash Volume|BNTC: Company Cash Volume|Company Cash and Cash Equivalents DSGN|Company Cash Funds Rocket Pharmaceuticals|Company Cash on Hand 4DMT (FDMT)|Company Cash Volume LXEO|Company Liquid Assets Korro Bio Inc.|Company Cash Volume EDIT (Editas Medicine Inc)|SLN: Company Cash and Cash Equivalents|PRQR - Company Cash Funds|Company Liquid Assets codexis.com CDXS|SGMO: Company Cash Volume|Nautilus Biotechnology (NAUT) - Company Cash Volume|Company Cash Funds Metagenomi, Inc|precisionbiosciences.com (DTIL) - Company Liquid Assets|Company Cash Funds Generation Bio Co. (GBIO)|Company Liquid Assets Boundless Bio, Inc.|Company Cash Funds Exicure, Inc. XCUR|IMNN: Company Cash and Cash Equivalents|PHIO - Company Cash Funds|Company Liquid Assets Mustang Bio MBIO|RNAZ: Company Cash Volume|Company Cash Position Bionano Genomics Inc. BNGO|APDN (Applied DNA Corp) - Company Cash Volume|bluebirdbio.com (BLUE) - Company Liquid Assets|Company Cash Volume IPA|Company Cash Volume Omega (OMGA)|Company Cash Funds Singular Genomics Systems Inc OMIC|Company Cash Volume Regulus RGLS|syros.com - Company Cash Volume|TBIO: Company Cash Funds|UBX: Company Cash Volume